Advertisement
Trump condemns middlemen in drug-pricing speech

Trump condemns middlemen in drug-pricing speech

By Alex Kacik and Virgil Dickson  |  May 11, 2018

The administration's proposal, coined American Patients First, recommended bolstering competition, allowing private plans to negotiate discounts for Medicare beneficiaries, creating incentives to lower list prices and reducing consumers' out-of-pocket spending.

CVS' pharmacy benefit manager unit sued for false claims

CVS' pharmacy benefit manager unit sued for false claims

By Tara Bannow  |  April 13, 2018

A recently unsealed False Claims Act lawsuit filed in 2014 accuses CVS Health, through its pharmacy benefits manager unit, of getting lower prices on drugs with its pharmacies and failing to pass those savings on to Medicare Part D.

CVS, Aetna shareholders greenlight merger

CVS, Aetna shareholders greenlight merger

By Alex Kacik  |  March 13, 2018

CVS Health and Aetna shareholders signed off on the proposed $69 billion merger of the two healthcare companies, which is expected to close in the second half of this year. Now they await the federal government's approval.

Cigna-Express Scripts deal unlikely to benefit consumers

Cigna-Express Scripts deal unlikely to benefit consumers

By Alex Kacik and Shelby Livingston  |  March 12, 2018

The $67 billion merger would allow Cigna to lower its costs by insourcing PBM services, and absorb the profits of the biggest stand-alone PBM at a time when its competitors are also pairing up with providers of pharmacy services.

Cigna to buy Express Scripts in $67 billion deal

Cigna to buy Express Scripts in $67 billion deal

By Shelby Livingston  |  March 08, 2018

Supply chain experts are skeptical the $67 billion Cigna Corp.-Express Scripts deal will do much to transform the healthcare industry, let alone deliver any significant savings to customers.

CVS Health eyes data, wage boosts with $1.5B tax benefit

CVS Health eyes data, wage boosts with $1.5B tax benefit

By Associated Press  |  February 09, 2018

CVS Health's fourth-quarter earnings nearly doubled, fueled by a $1.5 billion tax benefit that will help the drugstore chain expand its growing role in customer care. It plans on pumping more money into data analytics to help track prescription drug use and monitor patients' blood tests.

Aetna leadership to stay on after CVS deal

Aetna leadership to stay on after CVS deal

By Shelby Livingston  |  December 03, 2017

Aetna will operate as a stand-alone unit within CVS and will be run by the insurer's current management team. The deal would create a healthcare giant with more than $240 billion in annual revenue.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print